Continuous manufacturing and a quality-by-design development approach are a natural fit. FDA, as well as other regulatory agencies around the world, have for many years been encouraging drug makers to ...
Global regulatory authorities continue to push Quality-by-Design (QbD) in pharmaceutical development to support risk management. While QbD affords many important long-term benefits, these expectations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results